XML 17 R7.htm IDEA: XBRL DOCUMENT v3.7.0.1
Statements of Cash Flows - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Cash flow from operating activities:    
Net loss $ (6,526,014) $ (4,790,530)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 82,356 78,566
Vested stock options and warrants 165,271 871,877
Equity instruments issued for management and consulting 721,330 (6,667)
Issuance of common stock in cashless warrant exchange 736,725
Amortization of debt discount 219,097
Penalty on debt provision 10,031
(Gain) loss on Sales of Equipment (2,387) 17,076
Gain from sale of marketable securities (4,716)
Changes in assets and liabilities:    
Accounts receivable (636) 19,266
Inventories (40,468) 135,627
Prepaid expense and other assets 122,943 (81,564)
Accounts payable (430,301) (1,544,105)
Accrued expenses 791,459 (2,415,967)
Deferred Revenue 2,998
Net cash used in operating activities: (4,381,440) (7,487,293)
Cash flow from investing activities:    
Purchase of marketable securities (850,000)
Proceeds from sale of marketable securities 571,887
Purchase of certificates of deposit (1,100,000)
Redemption of certificates of deposit 1,000,000
Purchase of fixed assets (32,760) (32,470)
Purchase of intangibles (11,987) (28,095)
Net cash used in investing activities (422,860) (60,565)
Cash flow from financing activities:    
Proceeds from long-term and convertible debt 250,000
Principal payments on debt (933,074)
Net proceeds from issuance of preferred stock 18,950
Net proceeds from issuance of common stock 1,712,158 13,051,830
Net cash provided by financing activities 1,712,158 12,387,706
Net increase (decrease) in cash (3,092,142) 4,839,848
Cash at beginning of period 4,856,232 16,384
Cash at end of period 1,764,090 4,856,232
Non cash transactions:    
Common stock issued to satisfy debt $ 483,478